Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Submitted by
admin
on June 19, 2012 - 12:10pm
Source:
Seeking Alpha
News Tags:
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Headline:
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Do Not Allow Advertisers to Use My Personal information
